Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where cure possibilities remain limited. Utilize the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline https://financefeeds.com/intel-intc-shares-jump-by-around-14/